Molecular dynamics in drug design.

Area of Science:

• Computational chemistry
• Structural biology
• Drug discovery

Background:

• Molecular dynamics (MD) simulations are valuable for structure-based drug design.
• High-throughput screening campaigns often benefit from MD integration.

Purpose of the Study:

• To review recent publications utilizing explicit solvent MD simulations in drug design workflows.
• To illustrate the application of MD in refining protein targets and validating compound binding modes.

Main Methods:

• Review of literature integrating MD simulations with high-throughput docking.
• Application of MD before docking to generate alternative protein conformers.
• Post-docking MD simulations for binding mode assessment and hit optimization guidance.
• X-ray crystallography for final validation of predicted binding modes.

Main Results:

• MD simulations can precede docking to provide novel protein conformations.
• MD simulations serve as a crucial in silico filter to validate docking-predicted binding modes.
• MD simulations aid in guiding chemical synthesis for optimizing lead compounds.
• Successful in silico discovery of tyrosine kinase inhibitors and bromodomain antagonists.

Conclusions:

• Explicit solvent MD simulations are integral to modern structure-based drug design.
• Integrating MD simulations with docking and crystallography enhances drug discovery pipelines.
• MD simulations offer a powerful computational approach for predicting and validating drug-target interactions.